Cargando…
Poly-ε-Caprolactone/Fibrin-Alginate Scaffold: A New Pro-Angiogenic Composite Biomaterial for the Treatment of Bone Defects
We hypothesized that a composite of 3D porous melt-electrowritten poly-ɛ-caprolactone (PCL) coated throughout with a porous and slowly biodegradable fibrin/alginate (FA) matrix would accelerate bone repair due to its angiogenic potential. Scanning electron microscopy showed that the open pore struct...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512525/ https://www.ncbi.nlm.nih.gov/pubmed/34641215 http://dx.doi.org/10.3390/polym13193399 |
_version_ | 1784583013106974720 |
---|---|
author | Ren, Jiongyu Kohli, Nupur Sharma, Vaibhav Shakouri, Taleen Keskin-Erdogan, Zalike Saifzadeh, Siamak Brierly, Gary I. Knowles, Jonathan C. Woodruff, Maria A. García-Gareta, Elena |
author_facet | Ren, Jiongyu Kohli, Nupur Sharma, Vaibhav Shakouri, Taleen Keskin-Erdogan, Zalike Saifzadeh, Siamak Brierly, Gary I. Knowles, Jonathan C. Woodruff, Maria A. García-Gareta, Elena |
author_sort | Ren, Jiongyu |
collection | PubMed |
description | We hypothesized that a composite of 3D porous melt-electrowritten poly-ɛ-caprolactone (PCL) coated throughout with a porous and slowly biodegradable fibrin/alginate (FA) matrix would accelerate bone repair due to its angiogenic potential. Scanning electron microscopy showed that the open pore structure of the FA matrix was maintained in the PCL/FA composites. Fourier transform infrared spectroscopy and differential scanning calorimetry showed complete coverage of the PCL fibres by FA, and the PCL/FA crystallinity was decreased compared with PCL. In vitro cell work with osteoprogenitor cells showed that they preferentially bound to the FA component and proliferated on all scaffolds over 28 days. A chorioallantoic membrane assay showed more blood vessel infiltration into FA and PCL/FA compared with PCL, and a significantly higher number of bifurcation points for PCL/FA compared with both FA and PCL. Implantation into a rat cranial defect model followed by microcomputed tomography, histology, and immunohistochemistry after 4- and 12-weeks post operation showed fast early bone formation at week 4, with significantly higher bone formation for FA and PCL/FA compared with PCL. However, this phenomenon was not extrapolated to week 12. Therefore, for long-term bone regeneration, tuning of FA degradation to ensure syncing with new bone formation is likely necessary. |
format | Online Article Text |
id | pubmed-8512525 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85125252021-10-14 Poly-ε-Caprolactone/Fibrin-Alginate Scaffold: A New Pro-Angiogenic Composite Biomaterial for the Treatment of Bone Defects Ren, Jiongyu Kohli, Nupur Sharma, Vaibhav Shakouri, Taleen Keskin-Erdogan, Zalike Saifzadeh, Siamak Brierly, Gary I. Knowles, Jonathan C. Woodruff, Maria A. García-Gareta, Elena Polymers (Basel) Article We hypothesized that a composite of 3D porous melt-electrowritten poly-ɛ-caprolactone (PCL) coated throughout with a porous and slowly biodegradable fibrin/alginate (FA) matrix would accelerate bone repair due to its angiogenic potential. Scanning electron microscopy showed that the open pore structure of the FA matrix was maintained in the PCL/FA composites. Fourier transform infrared spectroscopy and differential scanning calorimetry showed complete coverage of the PCL fibres by FA, and the PCL/FA crystallinity was decreased compared with PCL. In vitro cell work with osteoprogenitor cells showed that they preferentially bound to the FA component and proliferated on all scaffolds over 28 days. A chorioallantoic membrane assay showed more blood vessel infiltration into FA and PCL/FA compared with PCL, and a significantly higher number of bifurcation points for PCL/FA compared with both FA and PCL. Implantation into a rat cranial defect model followed by microcomputed tomography, histology, and immunohistochemistry after 4- and 12-weeks post operation showed fast early bone formation at week 4, with significantly higher bone formation for FA and PCL/FA compared with PCL. However, this phenomenon was not extrapolated to week 12. Therefore, for long-term bone regeneration, tuning of FA degradation to ensure syncing with new bone formation is likely necessary. MDPI 2021-10-02 /pmc/articles/PMC8512525/ /pubmed/34641215 http://dx.doi.org/10.3390/polym13193399 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ren, Jiongyu Kohli, Nupur Sharma, Vaibhav Shakouri, Taleen Keskin-Erdogan, Zalike Saifzadeh, Siamak Brierly, Gary I. Knowles, Jonathan C. Woodruff, Maria A. García-Gareta, Elena Poly-ε-Caprolactone/Fibrin-Alginate Scaffold: A New Pro-Angiogenic Composite Biomaterial for the Treatment of Bone Defects |
title | Poly-ε-Caprolactone/Fibrin-Alginate Scaffold: A New Pro-Angiogenic Composite Biomaterial for the Treatment of Bone Defects |
title_full | Poly-ε-Caprolactone/Fibrin-Alginate Scaffold: A New Pro-Angiogenic Composite Biomaterial for the Treatment of Bone Defects |
title_fullStr | Poly-ε-Caprolactone/Fibrin-Alginate Scaffold: A New Pro-Angiogenic Composite Biomaterial for the Treatment of Bone Defects |
title_full_unstemmed | Poly-ε-Caprolactone/Fibrin-Alginate Scaffold: A New Pro-Angiogenic Composite Biomaterial for the Treatment of Bone Defects |
title_short | Poly-ε-Caprolactone/Fibrin-Alginate Scaffold: A New Pro-Angiogenic Composite Biomaterial for the Treatment of Bone Defects |
title_sort | poly-ε-caprolactone/fibrin-alginate scaffold: a new pro-angiogenic composite biomaterial for the treatment of bone defects |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512525/ https://www.ncbi.nlm.nih.gov/pubmed/34641215 http://dx.doi.org/10.3390/polym13193399 |
work_keys_str_mv | AT renjiongyu polyecaprolactonefibrinalginatescaffoldanewproangiogeniccompositebiomaterialforthetreatmentofbonedefects AT kohlinupur polyecaprolactonefibrinalginatescaffoldanewproangiogeniccompositebiomaterialforthetreatmentofbonedefects AT sharmavaibhav polyecaprolactonefibrinalginatescaffoldanewproangiogeniccompositebiomaterialforthetreatmentofbonedefects AT shakouritaleen polyecaprolactonefibrinalginatescaffoldanewproangiogeniccompositebiomaterialforthetreatmentofbonedefects AT keskinerdoganzalike polyecaprolactonefibrinalginatescaffoldanewproangiogeniccompositebiomaterialforthetreatmentofbonedefects AT saifzadehsiamak polyecaprolactonefibrinalginatescaffoldanewproangiogeniccompositebiomaterialforthetreatmentofbonedefects AT brierlygaryi polyecaprolactonefibrinalginatescaffoldanewproangiogeniccompositebiomaterialforthetreatmentofbonedefects AT knowlesjonathanc polyecaprolactonefibrinalginatescaffoldanewproangiogeniccompositebiomaterialforthetreatmentofbonedefects AT woodruffmariaa polyecaprolactonefibrinalginatescaffoldanewproangiogeniccompositebiomaterialforthetreatmentofbonedefects AT garciagaretaelena polyecaprolactonefibrinalginatescaffoldanewproangiogeniccompositebiomaterialforthetreatmentofbonedefects |